TP53 and neoplasm: Finally, the abnormal expression of p53 is investigated on MMR-proficient (MMRp) tumours to determine EC with (p53-abnormal–3rd subgroup) or without (nonspecific molecular profile/NSMP–4th subgroup) p53 anomalies [8,9].